In Q1'26, Johnson & Johnson's (JNJ) Gross Margin reached 71.5%, reflecting a notable rebound from the prior quarter's 67.6%. Operating Margin stood at 26.6%, indicating moderate operational efficiency, while Net Profit Margin was 21.8%, showing stable but unremarkable profitability after a period of fluctuation. Over the period from Q2'23 to Q1'26, Gross Margin exhibited volatility with an overall upward trend, peaking at 75.3% in Q4'23 before stabilizing around 67-70% in recent quarters, suggesting improved cost management amid supply chain pressures. Operating Margin displayed inconsistent performance, dipping to a low of 15.9% in Q4'24 due to potential one-time expenses, then recovering to highs near 29.3% in Q3'25, highlighting operational resilience. Net Profit Margin was the most erratic, with an outlier surge to 121.9% in Q3'23 likely from non-recurring gains, followed by a general range of 12-30% and a recent stabilization around 20-22%, underscoring the impact of extraordinary items on bottom-line trends.